Tvardi Therapeutics (TVRD) Operating Margin Growth (5y) (2018 - 2025)
Tvardi Therapeutics (TVRD) Operating Margin Growth (5y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tvardi Therapeutics | 17.36 Mn | 17.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 20,122.00 |
| Sep 30, 2024 | 30,937.00 |
| Jun 30, 2024 | -51,805.00 |
| Mar 31, 2024 | -86,158.00 |
| Dec 31, 2023 | -68,825.00 |
| Sep 30, 2023 | -18,953.00 |
| Jun 30, 2023 | 15,333.00 |
| Jun 30, 2022 | 1.41 Mn |
| Mar 31, 2022 | 186,791.00 |
| Mar 31, 2021 | 15.57 Mn |
| Sep 30, 2020 | 2,160.00 |
| Jun 30, 2020 | 19,641.00 |
| Mar 31, 2020 | 59,412.00 |
| Sep 30, 2019 | 5,549.00 |
| Jun 30, 2019 | 18,009.00 |
| Mar 31, 2019 | 139,398.00 |
| Dec 31, 2018 | -18,086.00 |
| Sep 30, 2018 | -5,651.00 |
| Jun 30, 2018 | -68,918.00 |